The LDH assay and Annexin V assay indicated that the two single-targeted CAR-T cells could eliminate CD38 + or LMP1 + NKTCL cells rapidly and efficiently. The gene discussed is CD38; the disease is extranodal nasal NK/T cell lymphoma.